"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ILMN. [ FAQ on what and how to ask] For non-ILMN questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Jacob Thaysen Ph.D.
Headquarter: 5200 Illumina Way, San Diego, CA, United States, 92122
Industry: Diagnostics & Research, Investment Track: NGS - gene, Employees: 8,600
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
My Watchlist
